MedTrace Logo

Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)

NCT00000518 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2016-01-21

No results posted yet for this study

Summary

To determine whether electrophysiologic study (EPS) or Holter monitoring (HM) was the better method for selecting effective long-term antiarrhythmic drug therapy in patients with sustained ventricular tachycardia, ventricular fibrillation, or an episode of aborted sudden death.

Conditions

Interventions

PROCEDURE

electrophysiology

PROCEDURE

electrocardiography, ambulatory

DRUG

imipramine

DRUG

mexiletine

DRUG

procainamide

DRUG

quinidine

DRUG

sotalol

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Utah

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1985-07-31
Completion
1992-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000518 on ClinicalTrials.gov